ArticleJournal of immunological methods2014

Diphtheria toxin-based bivalent human IL-2 fusion toxin with improved efficacy for targeting human CD25(+) cells.

Jaclyn Stromp Peraino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.